Search PubMed⌕ Search

Biomedical subjects

Louis M Guenin

Publications and source records attributed to Louis M Guenin.

10 recordsLinked to original sources

A proposed stem cell research policy.

The aspirations of scientists and patients for human embryonic stem cell (hESC) research in the U.S. motivate attention to the nitty-gritty of law and regulation and its confluence with such moral consensus as lies within our reach. Federal law and regulation form a tangle. Analysis yields several conclusions not widely appreciated. A legislative enactment is the rate-limiting step of federally funded research, the restriction of research imposed by the previous administration's policy as reprised in current proposals fails to achieve its objective of avoiding complicity in embryo sacrifice, the current administration's policy is another failed noncomplicity scheme under which research cannot be expanded without demolishing its putative justification, and the Food and Drug Administration has already effectively interdicted procreative cloning. While it is not plausible to deny complicity in embryo sacrifice when performing or funding hESC research, one can justify sacrifice of some embryos by an argument whose premises are consistent with a wide range of moral and religious views. This paper proposes a rule of public policy providing for the use of donated embryos barred from the womb. This rule would optimize research while manifesting its moral justification. The rule is suitable for implementation by any government that funds hESC research. The rule's justification provides a cogent argument for such incremental steps toward its implementation as become politically feasible from time to time.

Complicity↗

Wishful thinking will not obviate embryo use.

Upon hearing of purported nonembryo sources of human pluripotent stem cells, we need to ask not only whether the proposed sources yield such cells, but whether it is true as claimed that it would be morally better to shift to the purported alternatives. I argue that it would not be morally better. When we consider the morality of each proposal in turn, we find as to several that what defends them also defends the use of surplus embryos and clones in general. That leaves no reason to abandon the general case for the special case of compromised life forms. Another of the proposals is morally indefensible. Still other proposed techniques would themselves use or risk using embryos, not to mention that they may fail to produce pluripotent cells of sufficient quality. We shall not achieve a moral gain by adopting any of these proposals in lieu of using donated embryos barred from the womb by donor instructions.

Bioethical Issues↗

A failed noncomplicity scheme.

Present U.S. policy on funding embryonic stem cell research evidently rests on the supposition that, because the policy's announcement on August 9, 2001 came as a surprise, no one initiating a stem cell line prior thereto could reasonably have been induced to do so by the government. Hence it has been suggested that without complicity in embryo destruction, the government may fund studies of lines created before that date. The escape from complicity is illusory. The historical facts belie the supposition of noninducement. What is more, if, in order to meet demand for more and newer cell lines, the government stipulates some later date as the creation time of the oldest eligible cell line, that move will explode the policy's purported justification. The policy is as unavailing as a moral position as it is constringent for scientific progress.

Beginning of Human Life↗